| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 3.719 | 5.968 | 6.673 | 4.889 | 4.988 | 5.576 | 6.224 | 7.963 | 10.300 | 9.609 |
| Total Income - EUR | 3.719 | 5.968 | 6.673 | 4.889 | 5.199 | 5.576 | 6.224 | 7.963 | 10.370 | 9.892 |
| Total Expenses - EUR | 3.355 | 3.475 | 3.323 | 2.868 | 3.030 | 3.679 | 3.773 | 3.003 | 2.823 | 5.649 |
| Gross Profit/Loss - EUR | 364 | 2.493 | 3.350 | 2.021 | 2.168 | 1.896 | 2.451 | 4.961 | 7.547 | 4.244 |
| Net Profit/Loss - EUR | 252 | 2.318 | 3.150 | 1.880 | 2.012 | 1.737 | 2.268 | 4.727 | 6.298 | 3.515 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Neuropsi S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 7.918 | 7.265 | 6.579 | 6.020 | 5.474 | 4.948 | 0 | 0 | 0 | 5.377 |
| Current Assets | 566 | 1.236 | 767 | 646 | 1.833 | 692 | 3.281 | 4.831 | 11.417 | 5.218 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 309 | 306 | 301 | 258 | 248 | 0 | 0 | 0 | 0 | 0 |
| Cash | 257 | 930 | 466 | 388 | 1.585 | 692 | 3.281 | 4.831 | 11.417 | 5.218 |
| Shareholders Funds | -1.895 | 442 | 3.584 | 5.399 | 7.306 | 5.597 | 3.232 | 4.767 | 7.614 | 7.267 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 10.379 | 8.059 | 3.762 | 1.268 | 0 | 44 | 49 | 64 | 3.803 | 3.328 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Neuropsi S.r.l.